Document is current
Any future updates will be listed below
-
Authors
Feng, Yuan
Li, Yanjie
Xu, Mingxing
Meng, Hongyu
Dai, Cao
Yao, Zhicheng
-
Funding
Funding for this research was provided by:
national natural science foundation of china (82002544)
national natural science foundation of china (81760112)
national natural science foundation of china (82100560)
science and technology planning project of guangzhou city (202102010171)
chinese foundation for hepatitis prevention and control-tianqing liver disease research fund subject (TQGB20200048)
csco-roche solid tumor research project (Y-Roche2019/2-0041)
medical scientific research foundation of guangdong province (A2021110)
- License Information
-
More Information
Article History
Received: 29 July 2021
Accepted: 20 July 2022
First Online: 28 July 2022
Declarations
:
: This experiment was approved by the ethical committee of Guangzhou Forevergen Biosciences (Guangzhou, China).
: Not applicable.
: The authors declare no competing interests.
